Tinagl1 Gene Therapy Suppresses Growth and Remodels the Microenvironment of Triple Negative Breast Cancer
Author:
Affiliation:
1. Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States
Funder
National Cancer Institute
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.1c00008
Reference30 articles.
1. Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
2. Breast cancer statistics, 2017, racial disparity in mortality by state
3. Breast cancer statistics, 2019
4. Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling
5. Early Craniofacial Defects in Zebrafish that Have Reduced Function of a Wnt-Interacting Extracellular Matrix Protein, Tinagl1
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. YTHDF1 facilitates esophageal cancer progression via augmenting m6A-dependent TINAGL1 translation;Cellular Signalling;2024-10
2. Low TINAGL1 expression is a marker for poor prognosis in breast cancer;Journal of Cancer Research and Clinical Oncology;2022-10-14
3. Strategies targeting tumor immune and stromal microenvironment and their clinical relevance;Advanced Drug Delivery Reviews;2022-04
4. Down‐regulated TINAGL1 in fibroblasts impairs wound healing in diabetes;The FASEB Journal;2022-02-24
5. Evidence of Swim secretion and association with extracellular matrix in the Drosophila embryo;The International Journal of Developmental Biology;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3